GSTC

Globestar Therapeutics (PK) (GSTC)

Globestar Therapeutics Corporation (PK)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:GSTC

1 2 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/18	05 : 05	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2024/02/16	01 : 33	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2024/01/20	07 : 13	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2024/01/03	06 : 21	Edgar (US Regulatory)	Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2023/11/14	02 : 32	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2023/08/18	05 : 01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2023/08/15	05 : 31	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2023/06/28	06 : 12	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2023/05/31	19 : 03	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2023/05/16	05 : 16	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2023/05/04	02 : 35	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2023/05/04	02 : 30	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2023/04/07	05 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2023/02/14	07 : 17	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2023/01/10	03 : 48	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2022/12/30	06 : 37	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2022/08/23	06 : 31	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2022/08/16	05 : 29	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2022/05/17	05 : 55	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2021/10/12	21 : 28	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2021/10/04	21 : 49	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2021/09/20	21 : 17	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2018/11/17	07 : 30	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2018/11/17	07 : 25	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2018/11/17	07 : 04	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2018/11/15	00 : 50	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2018/11/15	00 : 40	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2018/11/15	00 : 38	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2018/11/14	23 : 44	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:GSTC	Globestar Therapeutics Corporation (PK)
2018/11/09	06 : 37	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:GSTC	Globestar Therapeutics Corporation (PK)